Financial highlights
180.3 £m See-through Revenue*
31.5 £m Underlying Profit Before Tax
4.36p Underlying Basic EPS
180.7 £m Statutory Revenue
-14.5 £m Reported Profit Before Tax
*Non-IFRS alternative performance measures. See-through revenue includes sales from Nizoral as if they had been invoiced by Alliance. For statutory accounting purposes the product margin on Nizoral sales is included within Revenue, in line with IFRS 15.
Results centre